Mumbai: Hexaware Technologies, a global IT services leader, has announced a strategic collaboration with Abluva, a pioneer in agentic AI security, to deliver secure and governed generative AI (GenAI) solutions for the Life Sciences industry.
With Life Sciences organizations increasingly leveraging agentic AI for research, clinical trials, patient data management, and commercialization, this partnership will empower enterprises to safely scale their AI adoption.
Also Read: Vaisala India Office Inaugurated in Mumbai, Targets Life Sciences and EV Sectors
The collaboration combines Hexaware Technologies’ domain expertise in clinical and regulatory frameworks with Abluva’s Secure Intelligence Plane, a next-gen platform designed to secure autonomous AI agents.
Key Features of the Hexaware Technologies – Abluva Partnership:
- Real-Time Agent Governance: Abluva’s Secure Intelligence Plane ensures AI agents operate within secure boundaries using mechanisms such as purpose binding, role-based context augmentation, tooling control, and data masking to mitigate unauthorized actions.
- End-to-End Agent Lifecycle Security: Comprehensive security protocols protect sensitive data across the entire AI lifecycle – from fine-tuning and Retrieval Augmented Generation (RAG) to prompt engineering – offering high-level visibility and protection in clinical environments.
- Autonomous Threat Detection and Self-Healing: With its patent-pending self-healing technology, Abluva’s platform can autonomously detect and resolve anomalous or risky behaviors in AI agents in real-time, reducing operational risks.
- Regulatory Compliance and Data Privacy: The integrated solution ensures full alignment with HIPAA, GDPR, and internal governance standards, delivering secure AI adoption with embedded compliance and audit trails.
Raj Gondhali, AVP & Head of Clinical Solutions at Hexaware Technologies, commented: “We are excited to partner with Abluva to offer the industry’s most secure agentic AI framework for leading life sciences sponsors and CROs. This alliance combines our global clinical delivery capabilities with Abluva’s advanced agent security solutions, ensuring responsible, compliant, and scalable AI transformation.”
Raj Darji, CEO of Abluva, said: “Our partnership with Hexaware Technologies reflects our commitment to making autonomous AI agents trustworthy and safe. With Hexaware’s vast reach in the life sciences domain and our security-driven innovation, we’re enabling organizations to unlock the true potential of GenAI.”
Amit Gautam, CTO of Abluva, added: “This collaboration allows us to bring real-time agent governance to enterprise life sciences settings. Together, we’re creating an enterprise-grade foundation for secure and responsible AI.”
Also Read: Biotech Startup Loopworm Secures USD 3.25M in Pre-Series A Round Led by WaterBridge Ventures
This alliance reaffirms Hexaware Technologies’ strategic focus on next-generation cloud and AI platforms, and Abluva’s mission to deliver enterprise-scale, research-driven agentic AI security. As the life sciences sector embraces digital transformation, the partnership will play a critical role in enabling secure, compliant, and scalable GenAI adoption.
